Nouvita Healthcare Ltd - Limited company accounts 22.3

REGISTERED NUMBER: 07440888 (England and Wales)

Group Strategic Report, Report of the Directors and

Consolidated Financial Statements for the Year Ended 30 June 2022

for

NOUVITA HEALTHCARE LTD

DIRECTORS:

L V Adams

P C Massetti

REGISTERED OFFICE:

Broad Oak Manor

Broad Oak End

Bramfield Road

Hertford

Hertfordshire

SG14 2JA

REGISTERED NUMBER:

07440888 (England and Wales)

AUDITORS:

Thorne Lancaster Parker

Chartered Accountants &

Statutory Auditors

4th Floor

Venture House

27-29 Glasshouse Street

London

W1B 5DF

The directors present their strategic report of the company and the group for the year ended 30 June 2022.

The primary activity of the Group in the year under review was that of providing in-patient and residential mental healthcare services including; psychiatric intensive care, rehabilitation and long term mental health residential care with and without nursing, primarily to the NHS. Nouvita Healthcare is also developing additional services which include supported living for young adults with Autism and Learning Disabilities.

The Group's strategy is one of continued growth through the expansion of existing facilities and also through the appropriate acquisition of hospitals, residential and nursing homes of suitable quality and location within the southeast of England.

REVIEW OF BUSINESS

2022

2021

2020

Turnover

£14,913,655

£12,549,108

£11,546,410

EBITDA

£2,952,178

£1,688,526

£771,556

Group turnover for the year was some £14,913,655 up approximately 19% from £12,549,108. EBITDA was £2,952,178 resulting in a Group Profit Before Tax of £2,364,752.

Whilst the group enjoyed a good improvement in performance, during the latter part of 2021 it continued to face significant pressure on staff costs and availability. Staffing remains a challenge the group will face in 2023, however, having started our overseas recruitment drive, it is showing signs that it will help.

We worked hard to reduce or eliminate lockdowns because of the pandemic and were not always as successful as we might have liked, however, our efforts to control costs tightly, implement the agency and continued work on marketing and the reduction of voids paid dividends.

As with last year, we continue to enjoy solid working relationships and brand reputation amongst our commissioners and care co-ordination teams both within the NHS and Local Authorities and have also enjoyed success in creating new working relationships across the length and breadth of the UK. Our next challenge is bed availability. We have plans to acquire new operations or build additional beds within our existing estate.

Cash and management time were in demand as we worked hard to complete the build and launch of Bushey Hall an eight bedded specialist unit that went live in August 2020 and appears to be attracting the interest of a number of commissioning groups. This continues to build.

The group has worked hard to continue the development of the Care Pathway, from hospital, through nursing units and on to supported living which is attractive to care commissioners.

Cash and bank loan positions at the year-end are considered to be sufficient to sustain the working capital and growth plans for the coming year.

PRINCIPAL RISKS AND UNCERTAINTIES

The directors analyse key risks to the business and monitor exposure to these risks on a regular basis.

Reputation risk

Provision of poor or inappropriate levels of care would cause severe damage to our CQC ratings, the Group's reputation, and the ability of the business to attract new residents. The business now operates sophisticated levels of performance monitoring systems with regular reporting to senior management and the directors of any potential issues. In addition, a comprehensive programme of service audits is undertaken across the homes with reports and resulting action plans being the subject of regular review. The directors encourage a culture of reporting any concerns from staff, residents and relatives all of which are appropriately investigated.

Health & Safety

The directors are of the view that no serious injury to staff, residents, their guests, or anyone else on the Group's premises is acceptable. Everyone in the business has accountability for health and safety, and they are given the necessary tools (including training, safety equipment and resources) to operate safely. Compliance is organised and monitored through a dedicated health and safety team across the business

Employment of staff

The Group relies on the skills and expertise of the staff employed. As the economy recovers, the shortage of appropriate labour is a potential risk to the business. This is particularly felt with the national shortage of qualified nursing staff. In order to mitigate this risk, the business has a proactive Human Resources and Recruitment team, including recruitment from overseas. The business continues to invest in a wide range of training courses both internally and externally. Management recognises that in order to deliver a high level of care, our people have to be trained to a very high standard of ability.

Covid-19 Risks

Covid-19 impacted upon staff availability coupled with additional requirements to cover sickness and additional infection control requirements. Whilst local authorities did channel government support costs for PPE, it did not make up for the need to increase fees to counter the steep rise in costs across the group and did not provide any financial support for the hospital services. At the time of approving our accounts, it is appropriate to make a statement regarding the effect the virus might have on the safety of our people, stakeholders and our financial performance.

Clearly, our people and our service user's safety are of paramount importance. If we have an outbreak at any of our locations, we must be able to isolate and contain the spread. The Group has already taken steps, as advised by the Department of Health, to minimise the risk to our staff and service users. The business continues to collect cash and we have increasing service user occupancy, However, as we discharge service users once they are moving along the Care Pathway and given the workload on our bed management teams, it is extremely difficult to predict the overall net impact on occupancy. We have put a number of cost cutting and cash conservation actions in place. These are unprecedented times and extremely difficult to forecast what the overall impact will be on the business.

We are perhaps in a better position than many businesses given the sector we operate in and that all of our business is contracted with the NHS and Local Authorities. Cash flow will hold up as long as service user occupancy remains stable and our staff can continue to work at current levels.

The Directors are pleased with the performance of the Group in the year to 30 June 2022 as trading performance has improved in the year and the Group continues to seek revenue growth in the coming year.

ON BEHALF OF THE BOARD:

P C Massetti - Director

7 February 2023

The directors present their report with the financial statements of the company and the group for the year ended 30 June 2022.

DIVIDENDS

A dividend was declared in the year of £500,000.

EVENTS SINCE THE END OF THE YEAR

Information relating to events since the end of the year is given in the notes to the financial statements.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 July 2021 to the date of this report.

L V Adams

P C Massetti

GOING CONCERN

The directors have reviewed the 12-month period cashflows to 30th June 2024. Based on the results of the review the directors believe the company has sufficient resources to continue as a going concern for the foreseeable future and as such consider the going concern basis for the preparation of the financial statements to be appropriate.

FINANCIAL INSTRUMENTS

The company's principal financial instruments consist of bank loans, cash and cash equivalents, trade creditors and trade debtors. The main purpose of these instruments is to finance the company's operations.

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

-	select suitable accounting policies and then apply them consistently;

-	make judgements and accounting estimates that are reasonable and prudent;

-	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

AUDITORS

The auditors, Thorne Lancaster Parker, are deemed to be re-appointed under Section 487(a) of the Companies Act 2006.

ON BEHALF OF THE BOARD:

P C Massetti - Director

7 February 2023

Opinion

We have audited the financial statements of Nouvita Healthcare Ltd (the 'parent company') and its subsidiaries (the 'group') for the year ended 30 June 2022 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Statement of Financial Position, Company Statement of Financial Position, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Statement of Cash Flows and Notes to the Consolidated Statement of Cash Flows, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

-	give a true and fair view of the state of the group's and of the parent company affairs as at 30 June 2022 and of the group's profit for the year then ended;

-	have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

-	have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

-	the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and

-	the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

-	adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

-	the parent company financial statements are not in agreement with the accounting records and returns; or

-	certain disclosures of directors' remuneration specified by law are not made; or

-	we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect irregularities, including fraud. The risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, or intentional misrepresentations, or through collusion. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below. However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the entity and management.

Our approach was as follows:

- We obtained an understanding of the legal and regulatory frameworks that are applicable to the Group and determined that the most significant are those that relate to the reporting framework (FRS 102 and the Companies Act 2006) and compliance with the relevant direct and indirect tax regulation in the United Kingdom. In addition, the Group has to comply with laws and regulations relating to its operations, including UK employment laws, health and safety, and GDPR.

- We understood how Nouvita Healthcare Limited is complying with those frameworks by making enquires with management and those charged with governance to understand how the Group maintains and communicates policies and procedures in these areas. We understood any controls put in place by management to reduce the opportunities of fraudulent transactions.

- We assessed the susceptibility of the Group's financial statements to material misstatements including how fraud might occur through internal team conversations and inquiry of management and those charged with governance. Through these procedures we determined there to be a risk of management override associated with revenue and a fraud risk around transactions at the year end. We have performed tests of detail, including understanding of the nature of the transactions, verifying that the margin is appropriate, and verifying the clerical accuracy of the revenue recognised. In relation to management override, we selected a sample from the entire population of journals, including manual journals, identifying specific transactions which did not meet our expectations, in order to investigate, understand and agree to source documentation. We selected a sample of revenue transactions recorded before the year end and obtained documentation to verify that revenue adjustments had been recorded in the appropriate period.

- Based on this understanding we designed our audit procedures to identify non-compliance with such laws and regulations. Our procedures involved verifying that material transactions are recorded in compliance with FRS 102 and where appropriate Companies Act 2006. Compliance with other operational laws and regulations were covered through our inquiry with no indication of non-compliance identified.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Neil Usher (Senior Statutory Auditor)

for and on behalf of Thorne Lancaster Parker

Chartered Accountants &

Statutory Auditors

4th Floor

Venture House

27-29 Glasshouse Street

London

W1B 5DF

9 February 2023

REVENUE

14,913,655

12,549,108

Cost of sales

11,075,831

9,867,456

GROSS PROFIT

3,837,824

2,681,652

Administrative expenses

1,215,315

1,283,296

2,622,509

1,398,356

Other operating income

1,958

480

OPERATING PROFIT

5

2,624,467

1,398,836

Exceptional items

6

-

108,343

2,624,467

1,507,179

Interest payable and similar expenses

7

259,715

218,581

PROFIT BEFORE TAXATION

2,364,752

1,288,598

Tax on profit

8

443,543

183,720

PROFIT FOR THE FINANCIAL YEAR

1,921,209

1,104,878

Profit attributable to:

Owners of the parent

1,921,209

1,104,878

PROFIT FOR THE YEAR

1,921,209

1,104,878

OTHER COMPREHENSIVE OTHER

COMPREHENSIVE INCOME

Income tax relating to other comprehensive other comprehensive income

-

-

OTHER COMPREHENSIVE FOR THE YEAR, NET OF INCOME TAX

-

-

TOTAL COMPREHENSIVE INCOME FOR THE YEAR

1,921,209

1,104,878

Total comprehensive income attributable to:

Owners of the parent

1,921,209

1,104,878

FIXED ASSETS

Property, plant and equipment

11

11,421,542

11,604,668

Investments

12

-

-

11,421,542

11,604,668

CURRENT ASSETS

Debtors: amounts falling due within one year

13

1,000,194

1,248,205

Debtors: amounts falling due after more than one year

13

5,812

20,770

Cash at bank and in hand

3,130,074

1,717,257

4,136,080

2,986,232

CREDITORS

Amounts falling due within one year

14

2,426,792

2,665,175

NET CURRENT ASSETS

1,709,288

321,057

TOTAL ASSETS LESS CURRENT LIABILITIES

13,130,830

11,925,725

CREDITORS

Amounts falling due after more than one year

15

(7,827,892

)

(8,055,496

)

PROVISIONS FOR LIABILITIES

19

(182,000

)

(170,500

)

NET ASSETS

5,120,938

3,699,729

CAPITAL AND RESERVES

Called up share capital

20

32,545

32,545

Retained earnings

21

5,088,393

3,667,184

SHAREHOLDERS' FUNDS

5,120,938

3,699,729

The financial statements were approved by the Board of Directors and authorised for issue on 7 February 2023 and were signed on its behalf by:

P C Massetti - Director

FIXED ASSETS

Property, plant and equipment

11

-

-

Investments

12

32,446

32,446

32,446

32,446

CURRENT ASSETS

Debtors: amounts falling due within one year

13

1,927,394

1,095,220

Debtors: amounts falling due after more than one year

13

6,639,694

7,876,434

Cash at bank

3,922

1,208

8,571,010

8,972,862

CREDITORS

Amounts falling due within one year

14

263,912

380,394

NET CURRENT ASSETS

8,307,098

8,592,468

TOTAL ASSETS LESS CURRENT LIABILITIES

8,339,544

8,624,914

CREDITORS

Amounts falling due after more than one year

15

7,827,892

8,055,496

NET ASSETS

511,652

569,418

CAPITAL AND RESERVES

Called up share capital

20

32,545

32,545

Retained earnings

21

479,107

536,873

SHAREHOLDERS' FUNDS

511,652

569,418

Company's profit for the financial year

442,234

563,824

The financial statements were approved by the Board of Directors and authorised for issue on 7 February 2023 and were signed on its behalf by:

P C Massetti - Director

Called up

share

Retained

Other

Total

capital

earnings

reserves

equity

£

£

£

£

Balance at 1 July 2020

32,545

2,577,271

63,853

2,673,669

Changes in equity

Total comprehensive income

-

1,104,878

-

1,104,878

Capital contribution

-

-

(78,818

)

(78,818

)

Transfer

-

(14,965

)

14,965

-

Balance at 30 June 2021

32,545

3,667,184

-

3,699,729

Changes in equity

Dividends

-

(500,000

)

-

(500,000

)

Total comprehensive income

-

1,921,209

-

1,921,209

Balance at 30 June 2022

32,545

5,088,393

-

5,120,938

Called up

share

Retained

Total

capital

earnings

equity

£

£

£

Balance at 1 July 2020

32,545

(26,951

)

5,594

Changes in equity

Total comprehensive income

-

563,824

563,824

Balance at 30 June 2021

32,545

536,873

569,418

Changes in equity

Dividends

-

(500,000

)

(500,000

)

Total comprehensive income

-

442,234

442,234

Balance at 30 June 2022

32,545

479,107

511,652

Cash flows from operating activities

Cash generated from operations

1

3,130,846

1,028,930

Interest paid

(243,751

)

(215,081

)

Finance costs paid

(15,964

)

(3,500

)

Exceptional items

-

108,343

Tax paid

(82,976

)

(78,924

)

Net cash from operating activities

2,788,155

839,768

Cash flows from investing activities

Purchase of tangible fixed assets

(160,548

)

(196,080

)

Net cash from investing activities

(160,548

)

(196,080

)

Cash flows from financing activities

Loan repayments in year

(338,712

)

(209,998

)

Capital repayments in year

(5,853

)

(7,023

)

Amount withdrawn by directors

(370,225

)

(391,147

)

Equity dividends paid

(500,000

)

-

Net cash from financing activities

(1,214,790

)

(608,168

)

Increase in cash and cash equivalents

1,412,817

35,520

Cash and cash equivalents at beginning of year

2

1,717,257

1,681,737

Cash and cash equivalents at end of year

2

3,130,074

1,717,257

1.	RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2022

2021

£

£

Profit before taxation

2,364,752

1,288,598

Depreciation charges

343,675

291,440

Exceptional items

-

(108,343

)

Finance costs

259,715

218,581

2,968,142

1,690,276

Decrease/(increase) in trade and other debtors

272,269

(395,072

)

Decrease in trade and other creditors

(109,565

)

(266,274

)

Cash generated from operations

3,130,846

1,028,930

2.	CASH AND CASH EQUIVALENTS

The amounts disclosed on the Statement of Cash Flows in respect of cash and cash equivalents are in respect of these Statement of Financial Position amounts:

Year ended 30 June 2022

30.6.22

1.7.21

£

£

Cash and cash equivalents

3,130,074

1,717,257

Year ended 30 June 2021

30.6.21

1.7.20

£

£

Cash and cash equivalents

1,717,257

1,681,737

3.	ANALYSIS OF CHANGES IN NET DEBT

At 1.7.21

Cash flow

At 30.6.22

£

£

£

Net cash

Cash at bank and in hand

1,717,257

1,412,817

3,130,074

1,717,257

1,412,817

3,130,074

Debt

Finance leases

(48,454

)

5,853

(42,601

)

Debts falling due within 1 year

(364,219

)

111,108

(253,111

)

Debts falling due after 1 year

(8,055,496

)

227,604

(7,827,892

)

(8,468,169

)

344,565

(8,123,604

)

Total

(6,750,912

)

1,757,382

(4,993,530

)

1.	STATUTORY INFORMATION

Nouvita Healthcare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The company has applied the merger accounting principles in accordance with FRS 102 in the preparation of the consolidated accounts. Under merger accounting, the carrying values of the assets and liabilities of the acquired entities are not adjusted to fair value, although appropriate adjustments are made to achieve uniformity of accounting policies where necessary.

The results and cashflows of all the combining entities are brought into the consolidated financial statements from the beginning of the financial year in which the combination occurred. In addition the comparative information is restated by including the results for all the combining entities for the previous reporting period and their balance sheet for the previous reporting date as if the entities had been combined throughout the prior period, adjusted as necessary to achieve uniformity of accounting policies.

These financial statements have been prepared on a going concern basis, under the historical cost convention.

The Company has taken advantage of the exemption in section 408 of the Companies Act from disclosing its individual profit and loss account.

Basis of consolidation

The consolidated accounts as at 30 June 2022 incorporate those of Nouvita Healthcare Limited and all of its subsidiaries.

The financial period of each subsidiary is co-terminus with that of the parent undertaking.

A subsidiary is an entity controlled by the Group, by virtue of holding a majority of the equity or an agreement with other investors. Control is the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities.

Where a subsidiary has different accounting policies to the group, adjustments are made to those subsidiary financial statements to apply the Group's accounting policies when preparing the consolidated financial statements.

All intra-group transactions, balances, and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Significant judgements and estimates

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including explanations of future events that are believe to be reasonable under the circumstances.

Key accounting estimates and assumptions

The Group makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are addressed below;

Useful economic life of property plant and equipment

The annual depreciation charge for property, plant and equipment is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are assessed annually. They are amended when necessary to reflect current estimates based on technological advancement, future investments, economic utilisation and the physical condition of the assets.

Going concern

The directors have reviewed the 12-month period cashflows to 30th June 2024. Based on the results of the review the directors believe the company has sufficient resources to continue as a going concern for the foreseeable future and as such consider the going concern basis for the preparation of the financial statements to be appropriate.

Turnover

Turnover

Revenue is recognised at the fair value of the consideration received or receivable for provision of services to external customers in the ordinary nature of the business. The fair value of the consideration takes into account discounts, settlement discounts and other rebates.

The Group recognises revenue when the amount of revenue can be measured reliably, and it is probable that future economic benefit will flow to the company.

Other income

Other income is recognised on an accruals basis and is presented within other operating income.

Tangible fixed assets

Property, plant and equipment are stated at cost (or deemed cost) less accumulated depreciation and accumulated impairment losses. Cost includes the original purchase price, costs directly attributable to bringing the asset to its working condition for its intended use, dismantling and restoration initially recorded at cost.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold Buildings

50 years

Short leasehold

2 years

Plant and machinery

4 years

Motor vehicles

4 years

No depreciation is charged on Freehold Land.

The carrying values of property plant and equipment are reviewed for impairment when events or changes in circumstances indicate the carrying value may not be recoverable.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.